519 related articles for article (PubMed ID: 12910248)
1. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
Young LS; Murray PG
Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus: 40 years on.
Young LS; Rickinson AB
Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.
Shah KM; Young LS
Clin Microbiol Infect; 2009 Nov; 15(11):982-8. PubMed ID: 19874382
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus, lymphomas and Hodgkin's disease.
Young LS; Rowe M
Semin Cancer Biol; 1992 Oct; 3(5):273-84. PubMed ID: 1335791
[TBL] [Abstract][Full Text] [Related]
6. EBV-associated neoplasms: alternative pathogenetic pathways.
Niller HH; Salamon D; Ilg K; Koroknai A; Banati F; Schwarzmann F; Wolf H; Minarovits J
Med Hypotheses; 2004; 62(3):387-91. PubMed ID: 14975509
[TBL] [Abstract][Full Text] [Related]
7. The LCR of EBV makes Burkitt's lymphoma endemic.
Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
[TBL] [Abstract][Full Text] [Related]
8. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
9. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection.
Barletta JM; Kingma DW; Ling Y; Charache P; Mann RB; Ambinder RF
Mol Cell Probes; 1993 Apr; 7(2):105-9. PubMed ID: 8391639
[TBL] [Abstract][Full Text] [Related]
10. [Epstein-Barr virus associated lymphocyte proliferation].
Stein H; Hummel M; Anagnostopoulos I; Korbjuhn P; Niedobitek G; Dallenbach F; Herbst H
Verh Dtsch Ges Pathol; 1992; 76():79-95. PubMed ID: 1283280
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of Epstein-Barr virus from latency.
Amon W; Farrell PJ
Rev Med Virol; 2005; 15(3):149-56. PubMed ID: 15546128
[TBL] [Abstract][Full Text] [Related]
12. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
Wang Y; Luo B; Zhao P; Huang BH
Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
[TBL] [Abstract][Full Text] [Related]
13. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
14. [Molecular pathological studies on Epstein-Barr virus (EBV) infected cells and EBV-associated tumor cells].
Yamamoto T; Hirai K
Nihon Rinsho; 1997 Feb; 55(2):452-60. PubMed ID: 9046840
[TBL] [Abstract][Full Text] [Related]
15. In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma.
Knox PG; Li QX; Rickinson AB; Young LS
Virology; 1996 Jan; 215(1):40-50. PubMed ID: 8553585
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression.
Seto E; Yang L; Middeldorp J; Sheen TS; Chen JY; Fukayama M; Eizuru Y; Ooka T; Takada K
J Med Virol; 2005 May; 76(1):82-8. PubMed ID: 15778977
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-associated cancers: aetiology and treatment.
Lopes V; Young LS; Murray PG
Herpes; 2003 Dec; 10(3):78-82. PubMed ID: 14759340
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
20. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
